Last reviewed · How we verify

NCT03568006

Effectiveness of Passive Mobilization in Patients With Subacromial Syndrome

Completed NA Last updated 19 September 2018
What this trial tests

NA trial testing Specific passive mobilization in Subacromial Impingement in 22 participants. Completed in 17 September 2018.

Timeline
1 July 2018
Primary endpoint
17 September 2018
17 September 2018

Quick facts

Lead sponsorUniversidad San Jorge
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposetreatment
Enrollment22
Start date1 July 2018
Primary completion17 September 2018
Estimated completion17 September 2018
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad San Jorge

Who can join

Adults 30 to 70, any sex, with Subacromial Impingement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

From a biomechanical point of view, subacromial syndrome causes an increment in the anterior and superior translation of the humeral head, which increases compression in the adjacent tissues of the subacromial space, aggravating the symptoms of the patients. Conservative treatments are the first option for subacromial syndrome management, despite the fact that there is limited evidence about its effectiveness, due to the lack of experimental studies. The aim of this study is to evaluate the effectiveness of a passive joint mobilization (caudal and dorsal gliding) grade II in the glenohumeral joint, within a multimodal approach to reduce pain and improve the range of motion in patients with subacromial syndrome.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other Universidad San Jorge trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03568006.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing